Selected article for: "high probability and International license"
Author: Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-Garcia; Anne Rutjes; Nicola Low; Jose A Perez-Molina; Javier Zamora
Title: FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW
  • Document date: 2020_4_21
    • ID: g8h6trql_54
    Snippet: Due to the multiple difficulties associated with the lack of reporting of included studies, and due to 316 the high probability of new studies being published in the short-term, we provided some 317 recommendations for future studies candidates to be included in an update of this review: 318 ï‚· Inclusion of a series of consecutive patients instead of selected groups, to avoid spectrum bias. 319 ï‚· Inclusion of a series of consecutive patients i.....
    Document: Due to the multiple difficulties associated with the lack of reporting of included studies, and due to 316 the high probability of new studies being published in the short-term, we provided some 317 recommendations for future studies candidates to be included in an update of this review: 318 ï‚· Inclusion of a series of consecutive patients instead of selected groups, to avoid spectrum bias. 319 ï‚· Inclusion of a series of consecutive patients instead of selected groups, to avoid spectrum bias 320 CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and future study: 1, 2, 3
    • cc NC ND International license and high probability: 1, 2, 3, 4
    • cc NC ND International license and include study: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and new study: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • consecutive patient and future study: 1, 2
    • consecutive patient and International license: 1
    • future study and high probability: 1, 2, 3
    • future study and include study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • future study and International license: 1, 2, 3
    • future study and new study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • future study and select group: 1
    • future study and short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high probability and include study: 1
    • high probability and International license: 1, 2, 3, 4, 5
    • high probability and new study: 1
    • high probability and short term: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • include study and short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15